Given the spectrum of therapeutic modalities for moderate-to-severe AD, can you provide a “therapeutic ladder” for how treatments, from corticosteroids to immunologically-based therapies should be sequenced in pediatric and adolescent patients?
Given the spectrum of therapeutic modalities for moderate-to-severe AD, can you provide a “therapeutic ladder” for how treatments, from corticosteroids to immunologically-based therapies should be sequenced in pediatric and adolescent patients?
Presenter
Clinical Assistant Professor of Dermatology and Pediatrics
Feinberg School of Medicine
Northwestern University
Chicago, Illinois